Skip to main content

Table 1 Characteristics of patients

From: N,N-Dimethylglycine in patients with progressive multiple sclerosis: result of a pilot double-blind, placebo, controlled randomized clinical trial

 

DMG

Placebo

Baseline (n = 20)

12 months (n = 17)

Baseline (n = 10)

12 months (n = 9)

Age (years)

54.9 ± 5.7

 

52.1 ± 5.9

 

Sex (M/F)

6/14

 

1/9

 

SPMS (M/F)

4/10

 

0/8

 

PPMS (M/F)

2/4

 

1/1

 

Weight (kg)

75.8 ± 16.3

 

75.6 ± 21.3

 

Height (cm)

167.6 ± 10.1

 

166.4 ± 7.1

 

Disease duration (years)

13.8 ± 9.3

 

18.8 ± 10.0

 

Study variables

 EDSS (score)

4.6 ± 2.0 (5.3)

4.5 ± 2.0 (4.5)

5.2 ± 1.5 (6.0)

5.3 ± 1.7 (6.0)

 FIS-D (score)

85.8 ± 26.8 (86.5)

76.0 ± 35.0 (86.0)

73.3 ± 25.7 (73.5)

81.6 ± 21.5 (89.0)

 PASAT (score)

40.6 ± 8.8 (39.0)

41.4 ± 12.0 (36.0)

35.6 ± 7.0 (34.0)

44.2 ± 9.7 (42.0)

 Gait velocity (km/h)

2.5 ± 1.1

2.5 ± 1.2

2.6 ± 0.7

2.6 ± 0.8

 Stride length (m)

0.50 ± 0.1

0.52 ± 0.2

0.49 ± 0.1

0.55 ± 0.2

 Stride variability (%)

4.2 ± 2.7

4.4 ± 4.5

12.9 ± 22.9

11.7 ± 17.1

 6 min Walking Test (m)

259.9 ± 141.8

267.2 ± 135.6

268.6 ± 80.5

277.3 ± 84.5

 Knee angle stance (left/2 + right/2)(°)

16.3 ± 4.9

16.4 ± 4.4

17.8 ± 7.5

17.5 ± 6.1

 Knee angle swing (left/2 + right/2)(°)

48.8 ± 10.5

49.1 ± 9.2

47.8 ± 7.7

49.7 ± 6.7

  1. SPMS secondary progressive MS, PPMS primary progressive MS, EDSS Expanded Disability Status Scale, FIS-D Fatigue Impact Scale, PASAT Paced Auditory Serial Addition Test, mean ± sd () = median